Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 10686 matches for

Tuesday 4 Feb 2020 is World Cancer Day (https://www.worldcancerday.org/). Led by the Union for International Cancer Control, the day aims to raise awareness and education about cancer.

SYMPLIFY Letter (upload Oct 24)

SYMPLIFY_ParticipantLetterAdditionalFollowUp_V519Aug24FINAL.pdf (184 KB)

SYMPLIFY_ParticipantLetterAdditionalFollowUpV519Aug24FINAL.pdf

SYMPLIFY_ParticipantLetterAdditionalFollowUpV519Aug24FINAL.pdf (184 KB)

SYMPLIFY_ParticipantLetterAdditionalFollowUpV519Aug24FINAL.pdf

SYMPLIFY_ParticipantLetterAdditionalFollowUpV519Aug24FINAL.pdf (184 KB)

Edit your oncology website profile

Oncology_-_Editing_Your_Web_Profile_SOP_-_v3_Feb_2020_.pdf (617 KB)

Anti-Bullying Information for Staff and Students

AntiBullyingInformationforStaffandStudents.pdf (392 KB)

Common Bullying Questions Answered

CommonBullyingQuestionsAnswered.pdf (381 KB)

SYMPLIFY NHS Digital Letter

SYMPLIFY_ParticipantLetterDARSNIC661736Y2Q9R_v1.1_10Nov2022_signed24Nov2022.pdf (138 KB)

TestdocforSYMPLIFY.docx

TestdocforSYMPLIFY.docx (11 KB)

University of Oxford, Department of Oncology, Athena SWAN Silver Application.pdf

This document is the Department of Oncology's application for an Athena SWAN silver level award.

University of Oxford, Department of Oncology, Athena SWAN Silver Application.pdf (2 MB)

University of Oxford, Department of Oncology 2020 Athena SWAN Action Plan.pdf

This document identifies the Department's key actions needed to realise its aims to further promote gender equality in higher education and research.

University of Oxford, Department of Oncology 2020 Athena SWAN Action Plan.pdf (373 KB)

Preclinical_SRF_MR-IGRT.pptx

Preclinical_SRF_MR-IGRT.pptx (17 MB)

TeamInductionChecklistNov19.pdf

TeamInductionChecklistNov19.pdf (110 KB)

Team Induction Checklist.pdf

Team Induction Checklist.pdf (107 KB)

OpenClinica Site Data Entry Guide.pdf

V4.0 Sep 2018

OCTO_OpenClinicaSiteDataEntryGuide_V4.0_19Sep2018.pdf (2 MB)

IPI-GLIO Study Schema.jpg

IPI-GLIO Study Schema.jpg (108 KB)

Similar stories

New Study Finds Common Virus May Improve Skin Cancer Treatment Outcomes

A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.

Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research

Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.

Machine Learning Enhances Detection of Multiple Cancer Types from Blood

Researchers from the University of Oxford have developed TriOx, a highly sensitive blood test that detects six cancers at their earliest stages. Published today in Nature Communications, the findings highlight the test’s potential to transform early cancer detection and improve patient outcomes.

MSc Medical Physics with Radiobiology receives IPEM accreditation

The Department of Oncology at the University of Oxford is delighted to announce that our new MSc Medical Physics with Radiobiology programme has received Masters Level Accreditation from the Institute of Physics and Engineering Medicine (IPEM).

Study Publishes New Insights on Goblet Cell Differentiation in Colorectal Cancer

The Oncology Department at the University of Oxford is excited to announce the forthcoming publication in the Proceedings of the National Academy of Sciences (PNAS) of the research paper “Goblet Cell Differentiation Subgroups in Colorectal Cancer.” This groundbreaking study sheds light on the role of goblet cell differentiation in colorectal cancer (CRC) and its impact on cancer progression and prognosis.

Ground-breaking Study reveals previously unknown genetic causes of Colorectal Cancer

A pioneering study, led by UK universities, including the University of Oxford, The Institute of Cancer Research, London, the University of Manchester and the University of Leeds, has provided the most comprehensive analysis to date of the genetic makeup of colorectal cancer (CRC).